profit from every $100 of sales.
$0$100
Lucyd
$0.84-1.92% today
-45.2% in 1 year
1-year low $0.651-year high $1.77
Trading in the middle of its range for the past year.
The essentials
Four questions every investor asks, answered in one line each.
more sales each year, on average, 2022 to 2025.
0%20% a year
It has no yearly profit to compare the price with.
CheapExpensive
It holds more cash than debt.
No debt5 years
Money in, money out
What Lucyd sold, what it kept, and what it did with the cash.
Sales went from $659,788 in 2022 to $2.66 million in 2025, with -$7.59 million of profit last year.
SalesProfit
Lucyd vs. similar companies
How it compares with the largest companies in its industry.
| Company | Profit from $100 of sales | Sales growth a year | Price per $1 of profit |
|---|---|---|---|
| Lucyd | No profit yet | ||
 Intuitive Surgical | 54.6× · Expensive | ||
 EssilorLuxottica Société anonyme | 36.1× · Expensive | ||
 Becton, Dickinson and | 34.8× · Expensive | ||
 Medline | 47.9× · Expensive |
AI analysis
An AI analyst reads Lucyd's last five years, its segments, earnings, insiders and peers, and writes the bull case, the bear case and what the price expects.
Run the AI analysisFull statementsIncome, balance sheet and cash flow, year by year
Income statement
| In millions of USD | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|
| 1 | 1 | 2 | 3 | |
| -0 | -0 | 0 | 1 | |
| -6 | -7 | -8 | -8 | |
| -6 | -7 | -8 | -8 | |
| -6 | -7 | -8 | -8 | |
| -17.40 | -10.87 | -5.19 | -1.90 | |
| -8.5% | -10.4% | 13.1% | 21.3% | |
| -845.2% | -594.9% | -484.2% | -319.2% | |
| -861.2% | -578.2% | -474.6% | -285.2% |
Balance sheet
| In millions of USD | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|
| Total assets | 5 | 6 | 10 | 10 |
| Cash | 4 | 4 | 3 | 7 |
| Total debt | 0 | – | – | – |
| Total liabilities | 1 | 1 | 1 | 1 |
| 4 | 6 | 9 | 9 | |
| 0 | 1 | 1 | 4 | |
| -107.8% | -94.7% | -68.8% | -74.0% | |
| -141.2% | -119.9% | -85.4% | -83.7% |
Cash flow
| In millions of USD | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|
| -3 | -6 | -7 | -7 | |
| 0 | 0 | 0 | 0 | |
| -3 | -6 | -7 | -8 | |
| Dividends paid | – | – | – | – |
| – | – | – | – | |
| 1 | 1 | 1 | 1 |
Valuation
- –
- –
- –
- 0.6×
- 2.8×
- –
- –
- -102.3%
- -103.2%
- 0.0%
Profitability
- 21.3%
- -319.2%
- -285.2%
- -314.1%
- -75.9%
- -88.5%
- -0.3%
- -0.1%
- -0.1%
- 27.3%
Growth
- +59.2%
- –
- −4.9%
- –
- +130.4%
Financial health
- -0.8×
- 0.00
- 0.0%
- –
- 9.03
- 8.61
- 0.00
How it ranks in Healthcare
Each dot is where the company stands among every company over $300M in the sector. Further right is better.
Bottom 1%of 958
Top 10%of 889
Recent earnings
Our results feed has not updated since May 21, 2026. Results reported after that are not in this table yet.
| Date | EPS | Expected | Surprise |
|---|---|---|---|
| May 14, 2026 | -0.37 | -0.47 | +21.3% |
| Mar 25, 2026 | -0.28 | -0.43 | +34.9% |
| Nov 13, 2025 | -0.38 | -0.49 | +22.4% |
| Aug 14, 2025 | -0.66 | -0.77 | +14.3% |
| May 13, 2025 | -0.72 | -0.73 | +1.4% |
| Mar 24, 2025 | -0.41 | -1.22 | +66.4% |
| Nov 12, 2024 | -0.99 | -1.60 | +38.1% |
| Aug 12, 2024 | -1.87 | -1.60 | −16.9% |
News
Innovative Eyewear to roll out Lucyd Armor in 150 plus U.S. storesSeeking Alpha · Aug 24, 2026The newest story we have is from Aug 24, 2026.
Insider trades
Our insider feed has not updated since May 26, 2026. Trades filed after that are not listed yet.
No insider trades on file.
The seven classic investing rulebooks
2/7Passes 2 of 7. Each bar is how well the company fits that investor's published rules, from 0 to 100; 60 or more counts as a pass.
Warren Buffett
40No pass
Benjamin Graham
77Pass
Philip Fisher
47No pass
Peter Lynch
71Pass
Joel Greenblatt
0No pass
Charlie Munger
41No pass
Terry Smith
41No pass
Questions about Lucyd
Is Lucyd a good stock to buy?
A business with weak numbers that is not profitable yet. 2 of the 7 famous investors' published rulebooks we apply pass it. Whether it suits you depends on your goals and the price you pay; invest-like never tells anyone to buy or sell. The AI analysis lays out the case for and against. Read the Lucyd AI analysis
What does Lucyd do?
Lucyd, Inc develops and sells smart eyewear in North America. It is in Medical Instruments & Supplies.
Does Lucyd pay a dividend?
No. Lucyd does not pay a dividend at the moment.
Is Lucyd stock halal?
No. Lucyd does not pass our halal screen: its cash and confirmed interest-bearing investments are 89% of its market value, at or above the 33% limit. How we check
How has Lucyd stock done over the past year?
Down 45.2% over the past twelve months, to $0.84. It traded between $0.65 and $1.77 and is 52.3% below its high.
Who are Lucyd's competitors?
The largest listed companies in the same industry are Intuitive Surgical, EssilorLuxottica Société anonyme, Becton, Dickinson and and Medline. The peers table on this page compares their profit, growth and price with Lucyd's.
Prices: daily closes to Nov 11, 2026. Fundamentals: company reports via invest-like data.